Medicenna Therapeutics Corp.


Date:

(MENAFN- Baystreet) 09:47 AM EST - Medicenna Therapeutics Corp.: Today reported financial results and corporate highlights for the fiscal quarter ended September 30, 2026. Net loss for the quarter was $4.0 million, or $0.04 per share, compared with a net loss of $4.9 million, or $0.06 per share, for the corresponding period in 2025. Medicenna Therapeutics Corp. shares T are trading down $0.005 at $0.36.

MENAFN17112026000212011056ID1111976776


Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search